UroGen Pharma Ltd Net Asset Quality Index
UroGen Pharma Ltd net asset quality index. UroGen Pharma Ltd (URGN) has a Net Asset Quality Index of -52.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $252.59 Million minus total liabilities of $384.99 Million yields net assets of $-132.40 Million. A higher index indicates a stronger, lower-leverage balance sheet. See URGN total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of UroGen Pharma Ltd (2013–2025)
Net asset quality index of UroGen Pharma Ltd from 2013 to 2025. This chart shows how UroGen Pharma Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at -52.4%, representing net assets of $-132.40 Million against total assets of $252.59 Million USD. Check UroGen Pharma Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
UroGen Pharma Ltd Net Asset Quality Index by Year (2013–2025)
UroGen Pharma Ltd net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for UroGen Pharma Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is UroGen Pharma Ltd worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -52.6% | $-105.47 Million | $200.46 Million | $305.93 Million | ▼ -49.5 pp |
| 2024 | -3.1% | $-8.80 Million | $285.71 Million | $294.51 Million | ▲ +33.5 pp |
| 2023 | -36.6% | $-65.21 Million | $178.31 Million | $243.52 Million | ▲ +29.3 pp |
| 2022 | -65.9% | $-89.36 Million | $135.62 Million | $224.98 Million | ▼ -72.9 pp |
| 2021 | 7.0% | $8.41 Million | $119.75 Million | $111.33 Million | ▼ -72.0 pp |
| 2020 | 79.0% | $96.36 Million | $122.00 Million | $25.65 Million | ▼ -10.1 pp |
| 2019 | 89.1% | $180.30 Million | $202.39 Million | $22.09 Million | ▲ +2.1 pp |
| 2018 | 87.0% | $90.09 Million | $103.56 Million | $13.46 Million | ▼ -3.7 pp |
| 2017 | 90.7% | $68.52 Million | $75.55 Million | $7.04 Million | ▲ +20.0 pp |
| 2016 | 70.7% | $16.31 Million | $23.06 Million | $6.75 Million | ▼ -17.7 pp |
| 2015 | 88.5% | $17.15 Million | $19.39 Million | $2.24 Million | ▲ +8.9 pp |
| 2014 | 79.6% | $3.47 Million | $4.36 Million | $891.00K | ▼ -5.4 pp |
| 2013 | 85.0% | $2.74 Million | $3.23 Million | $484.00K | — |